Abstract:Background: Long-term immunosuppressive maintenance therapy is necessary to prevent the rejection of xenografts. However, it is still unclear which oral immunosuppressant is most suitable for pig-to-human xenotransplantation . Methods: A xenogeneic mixed lymphocyte reaction (MLR) system was established using peripheral blood mononuclear cells (PBMCs) isolated from wildtype (WT) or GTKO/CMAHKO/β4GalNT2KO (TKO) pigs as stimulator cells and human PBMCs as responder cells. Various concentrations of tacrolimus (Tac), cyclosporine (CsA), or rapamycin (Rapa) were added to the MLR system as interventions. The inhibitory effects of the three immunosuppressants on the proliferation and cytokine production of human T cells were studied and compared. The inhibitory effect of anti-CD154 mAb alone or in combination with Tac/CsA/Rapa on xenoreactive MLR was also investigated. Results: PBMCs from both WT and TKO pigs stimulated significant proliferation of human T cells. Tac had a strong inhibitory effect on human T-cell proliferation stimulated by pig PBMCs. CsA inhibited human T-cell proliferation in a typical dose-dependent manner. When Tac and CsA concentrations reached 5 and 200 ng/mL, respectively, the proliferation rates of CD3+/CD4+/CD8+ T cells were reduced almost to a negative level. Even at high concentrations, Rapa had only a moderate inhibitory effect on xenogeneic MLR. The inhibitory effects of these three immunosuppressants on xenogeneic T-cell responses were further confirmed by the detection of CD25 expression and supernatant cytokines (IL-2, IL-6, IFN-γ, TNF-α, IL-4, IL-10, and IL-17). Although anti-CD154 mAb monotherapy showed only moderate inhibitory effects on xenoreactive T-cell proliferation, low-dose anti-CD154 mAb combined with low-dose Tac, CSA, or Rapa could produce significant synergistic inhibitory effects. Conclusion: Tac is more efficient than CsA or Rapa in inhibiting xenogeneic T-cell responses in vitro. If used in combination with anti-CD154 mAb, all the three immunosuppressants can achieve satisfactory synergistic inhibitory effects.

Immunosuppressive activities of immunosuppressant F904

The Inhibitory Effects of F904 on T Cell Activation and the Up-regulatory Effect of Exogenolls IL-2 in the Process

Sirolimus F904 and Its Derivative FIM-A (ap23573)anticncer Activity in Vitro

Research Progress of Novel Immunosuppressant FTY720

Purification, identification and biological activities of a lipopeptide compound FW523 from a marine Micromonospora chalcea FIM 02-523

Stemucronatoside K, a Novel C21 Steroidal Glycoside from Stephanotis Mucronata, Inhibited the Cellular and Humoral Immune Response in Mice

The Biological Activities of a Novel Immunosuppressive Agent FK520

Short-term Pharmacological Inhibition of MyD88 Homodimerization by a Novel Inhibitor Promotes Robust Allograft Tolerance in Mouse Cardiac and Skin Transplantation.

Stephanthraniline A And Cyclosporine A Synergize To Inhibit T-Cell Response In Vitro And In Vivo

EFFECT OF A NEW IMMUNOSUPPRESSIVE AGENT, FK506, ON HUMAN LYMPHOCYTE RESPONSES IN VITRO: I. Inhibition of Expression of Alloanticen‐Activated Suppressor Cells, As Well As Induction of Alloreactivity

FR65814, a novel immunosuppressant isolated from a Penicillium strain. Taxonomy, fermentation, isolation, physico-chemical and biological characteristics and structure assignment

PO‐322 Exerts Potent Immunosuppressive Effects in Vitro and in Vivo by Selectively Inhibiting SGK1 Activity

Biosynthesis Of The Immunosuppressant (-)-Fr901483

The Immunosuppressive Effect of Rapamycin on Lymphocytic Proliferation and DTH、GVHR

A Benzoxazole Derivative PO-296 Inhibits T Lymphocyte Proliferation by the JAK3/STAT5 Signal Pathway

Immuno-enhancement effects of Shenqi Fuzheng Injection on cyclophosphamide-induced immunosuppression in Balb/c mice

A Novel Derivative of (-)mycousnine Produced by the Endophytic Fungus Mycosphaerella nawae, Exhibits High and Selective Immunosuppressive Activity on T Cells

Comparative Inhibitory Effects of Tacrolimus, Cyclosporine, and Rapamycin on Human Anti-Pig Xenogeneic Mixed Lymphocyte Reactions

Screening of higher-yield sirolimus producer, mutant FC 904-33

In vitro and in vivo immunomodulatory effects of fucoidan compound agents

Effects of Recombined Procine Lactoferrin-N on Immunological Function in Immunosuppressive Mice Induced by Cyclophosphamide